Verastem (VSTM) Total Current Liabilities (2011 - 2026)
Verastem (VSTM) posted quarterly Total Current Liabilities of $66.8 million for Q1 2026, up 87.67% year-over-year from $35.6 million in Q1 2025, and down 7.5% quarter-over-quarter from $72.3 million in Q4 2025.
Analysis
Verastem (VSTM) Total Current Liabilities (2011 - 2026) Analysis & Trends
Verastem's Total Current Liabilities history runs 16 years deep, the most recent figure standing at $66.8 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 87.67% year-over-year to $66.8 million; the TTM figure through Mar 2026 stood at $66.8 million (up 87.67% YoY), while the FY2025 annual figure was $72.3 million, up 133.33% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $66.8 million, down from $72.3 million in the prior quarter.
- The five-year high for Total Current Liabilities was $72.3 million in Q4 2025, with the low at $16.9 million in Q1 2022.
- The 5-year median for Total Current Liabilities is $26.7 million (2024), against an average of $34.4 million.
- The sharpest annual moves came in 2023 and 2025: Total Current Liabilities gained 3.46% in 2023, then jumped 133.33% in 2025.
- Verastem's Total Current Liabilities stood at $21.7 million in 2022, then gained by 21.77% to $26.4 million in 2023, then grew by 17.41% to $31.0 million in 2024, then jumped by 133.33% to $72.3 million in 2025, then retreated by 7.5% to $66.8 million in 2026.
- Business Quant data shows VSTM's Total Current Liabilities at $66.8 million in Q1 2026, $72.3 million in Q4 2025, and $59.7 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 2.53 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 354.06 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.51 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 630.93 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Verastem | 814.94 Mn | 678.59 Mn | 36.32 Mn | 78.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 78.13 Mn |
| Mar 31, 2026 | 66.85 Mn |
| Dec 31, 2025 | 72.27 Mn |
| Sep 30, 2025 | 59.71 Mn |
| Jun 30, 2025 | 50.36 Mn |
| Mar 31, 2025 | 35.62 Mn |
| Dec 31, 2024 | 30.97 Mn |
| Sep 30, 2024 | 37.37 Mn |
| Jun 30, 2024 | 30.35 Mn |
| Mar 31, 2024 | 26.73 Mn |
| Dec 31, 2023 | 26.38 Mn |
| Sep 30, 2023 | 23.81 Mn |
| Jun 30, 2023 | 20.79 Mn |
| Mar 31, 2023 | 22.36 Mn |
| Dec 31, 2022 | 21.66 Mn |
| Sep 30, 2022 | 21.87 Mn |
| Jun 30, 2022 | 20.09 Mn |
| Mar 31, 2022 | 16.89 Mn |
| Dec 31, 2021 | 18.59 Mn |
| Sep 30, 2021 | 13.54 Mn |